Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-FAPI-XT117 + 64Cu-FAPI-XT117
- Development stage
- Unknown
- Lead developer
- Sinotau Pharmaceutical Group
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
A combination diagnostic radiopharmaceutical composed of **FAPI-XT117**, a fibroblast activation protein inhibitor (FAPi), labeled with two different radionuclides: **gallium-68** and **copper-64**. Both components are used as PET imaging agents to non-invasively visualize the presence of **fibroblast activation protein (FAP)**, which is highly expressed in cancer-associated fibroblasts in the tumor microenvironment of many solid tumors. The combined formulation allows the assessment of biodistribution, tumor uptake, and pharmacokinetics at different time-points associated with the half-lives of the radionuclides. The primary indication is imaging of FAP-positive tumors for diagnosis, characterization, or pre-therapeutic assessment in oncology.[7][2]
- Other names
- gallium Ga 68/copper Cu 64-labeled FAPI-XT117
02
Targets
FAP (Fibroblast activation protein alpha)
Beyond the preview
Go deeper on 68Ga-FAPI-XT117 + 64Cu-FAPI-XT117.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-FAPI-XT117 + 64Cu-FAPI-XT117.